V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough

Augmedix Executive Compensation (FY22)

AUGX · Executive and director compensation, fiscal 2022 only

The paid brief on Augmedix

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
Data as of September 7, 2026Latest filing (DEF 14A): June 26, 2023
1 filing cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Augmedix brief$1,500Get the executive brief
57 figures on this page, cited to the filing that reported them. See the citations
Chief executive, fiscal 2022
◇
Emmanuel Krakaris

More on Augmedix

Five data products on this company. Each one is requested through the developer setup page.

Frequently asked questions

Answers drawn from the data on this page.
Who is Augmedix's chief executive and what were they paid?
Emmanuel Krakaris was paid $1,157,484 in total compensation as President, Chief Executive Officer and Secretary for fiscal 2022.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Emmanuel Krakaris
President, Chief Executive Officer and Secretary
◇——◇◇—◇◇
Sandra Breber
Chief Operating Officer
◇——◇◇—◇— not reconciled
Saurav Chatterjee
Chief Technology Officer
◇——◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2022 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Saurav ChatterjeeOption◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
Sandra BreberOption◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
Emmanuel KrakarisOption◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2023
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
William J. Febbo
◇◇◇———◇
Margie L. Traylor
◇◇◇———◇
Laurie McGraw
Lead independent director
◇◇◇———◇
Jason Krikorian
◇◇————◇
Joseph W. Marks
◇◇————◇
Jennifer Carter, Ian Shakil, Robert Faulkner, Emmanuel Krakaris, Gerard van Hamel Platerink and Roderick H. O'Reilly served on the board in fiscal 2023 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Augmedix files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Augmedix disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Augmedix's disclosed peer group is defensible, who names Augmedix back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
57 figures on this page, cited to the filing that reported them.
57 cited to the filing

Documents cited

  1. 0001213900-23-051693
    DIRECTOR COMPENSATION · Director Compensation Table · Outstanding Equity Awards at 2022 Fiscal · Summary Compensation Table
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Augmedix executive compensation, FY2022.” https://intel.velarion.ai/comp/AUGX (accessed 2026).
Short form: data: Velarion

The paid brief for Augmedix

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
1 filing cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Augmedix and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy